| ASSET | DATE | % RETURN |
|---|---|---|
Vyne Therapeutics (VYNE) | 1/4/2023 | 68.79% |
Eightco (ORBS) | 1/4/2023 | 52.17% |
Kala Pharmaceuticals (KALA) | 1/4/2023 | 47.58% |
Kuke Music (KUKE) | 1/4/2023 | 45.48% |
Entero Therapeutics (GRDX) | 1/4/2023 | 36.48% |
Entero Therapeutics (ENTO) | 1/4/2023 | 36.48% |
I-Mab (IMAB) | 1/4/2023 | 30.59% |
NovaBridge Biosciences (NBP) | 1/4/2023 | 30.59% |
Myseum (MYSE) | 1/4/2023 | 29.41% |
Scworx (WORX) | 1/4/2023 | 26.48% |
Sunlands Technology (STG) | 1/4/2023 | 25.81% |
Nuvve (NVVE) | 1/4/2023 | 25% |
Burning Rock Biotech (BNR) | 1/4/2023 | 24.42% |
N2OFF (NITO) | 1/4/2023 | 23.7% |
Greenidge Generation (GREE) | 1/4/2023 | 23.33% |
iPower (IPW) | 1/4/2023 | 20.95% |
Alvarium Tiedemann (ALTI) | 1/4/2023 | 20.71% |
Immunome (IMNM) | 1/4/2023 | 20.25% |
VistaGen Therapeutics (VTGN) | 1/4/2023 | 20.23% |
Bone Biologics (BBLG) | 1/4/2023 | 20% |
Kaixin Auto (KXIN) | 1/4/2023 | 20% |
Anghami (ANGH) | 1/4/2023 | 19.74% |
Tharimmune (THAR) | 1/4/2023 | 19.32% |
Marygold Companies (MGLD) | 1/4/2023 | 19.08% |
Sophia Genetics (SOPH) | 1/4/2023 | 18.92% |
